SCHEMBL2810088

SCHEMBL2810088

CC(=COCc1ccccc1)C(=O)Nc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.44
SGMS2 Q8NHU3 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN6 P29350 1/20 0.44
PTPN11 Q06124 1/20 0.44
EPHX2 P34913 1/20 0.44
POLB P06746 1/20 0.42
BRD4 O60885 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810082 1.00 RAB9A (0.47) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL2808822 0.80 ALDH1A1 (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2BRD4
SCHEMBL981849 0.80 ALDH1A1 (0.53) RAB9ANPC1ALDH1A1SMN1; SMN2BRD4
SCHEMBL28171828 0.80 ALDH1A1 (0.49) RAB9ANPC1CASP3SENP8SENP7
SCHEMBL2811474 0.76 NAPRT (0.48) RAB9ANPC1ALDH1A1SMN1; SMN2NAPRT
SCHEMBL2811479 0.76 NAPRT (0.48) RAB9ANPC1ALDH1A1SMN1; SMN2NAPRT
SCHEMBL2322470 0.75 NAPRT (0.59) RAB9ANPC1ALDH1A1SMN1; SMN2NAPRT
SCHEMBL2322466 0.75 NAPRT (0.59) RAB9ANPC1ALDH1A1SMN1; SMN2NAPRT
SCHEMBL2358808 0.75 NAPRT (0.59) RAB9ANPC1ALDH1A1SMN1; SMN2NAPRT
SCHEMBL2808721 0.74 RAB9A (0.58) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 RAB9A 1842/4885NPC1 3668/4885CASP3 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.